![Pierre Gianello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Gianello
Director/Board Member at
NYXOAH SA
Net worth: 37 270 $ as of 2026-06-29
Profile
Pierre Gianello is the founder of SYnAbs SA, which was founded in 2015.
He is currently a Director at Brussels Life Science Incubator SA and a Director at Pig For Life SA. He is also a Non-Executive Director at Nyxoah SA since 2018.
Dr. Gianello's former positions include being a Director at BruCells NV and Fetus For Life.
He was also a Professor at Katholieke Universiteit Leuven from 1997 to 2011.
Dr. Gianello holds a doctorate degree from Université Catholique de Louvain.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NYXOAH SA 0.02% | 2026-02-28 | 21,560 ( 0.02% ) | 37 270 $ | 2026-06-29 |
Pierre Gianello active positions
| Companies | Position | Start |
|---|---|---|
| NYXOAH SA | Director/Board Member | 2018-03-26 |
Brussels Life Science Incubator SA
 Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Director/Board Member | - |
Pig For Life SA
 Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Director/Board Member | - |
Former positions of Pierre Gianello
| Companies | Position | End |
|---|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2010-12-31 |
Fetus For Life | Director/Board Member | - |
SynAbs SA
 SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Founder | - |
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Director/Board Member | - |
Training of Pierre Gianello
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brussels Life Science Incubator SA
Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Finance |
Nyxoah SA
 Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
SynAbs SA
SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Health Technology |
Pig For Life SA
Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Process Industries |
Fetus For Life |
- Stock Market
- Insiders
- Pierre Gianello
